Literature DB >> 17261599

Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model.

Abiodun D Ogunniyi1, Kim S LeMessurier, Rikki M A Graham, James M Watt, David E Briles, Uwe H Stroeher, James C Paton.   

Abstract

Successful colonization of the upper respiratory tract by Streptococcus pneumoniae is an essential first step in the pathogenesis of pneumococcal disease. However, the bacterial and host factors that provoke the progression from asymptomatic colonization to invasive disease are yet to be fully defined. In this study, we investigated the effects of single and combined mutations in genes encoding pneumolysin (Ply), pneumococcal surface protein A (PspA), and pneumococcal surface protein C (PspC, also known as choline-binding protein A) on the pathogenicity of Streptococcus pneumoniae serotype 2 (D39) in mice. Following intranasal challenge with D39, stable colonization of the nasopharynx was maintained over a 7-day period at a level of approximately 10(5) bacteria per mouse. The abilities of the mutant deficient in PspA to colonize the nasopharynx and to cause lung infection and bacteremia were significantly reduced. Likewise, the PspC mutant and, to a lesser extent, the Ply mutant also had reduced abilities to colonize the nasopharynx. As expected, the double mutants colonized less well than the parent to various degrees and had difficulty translocating to the lungs and blood. A significant additive attenuation was observed for the double and triple mutants in pneumonia and systemic disease models. Surprisingly, the colonization profile of the derivative lacking all three proteins was similar to that of the wild type, indicating virulence gene compensation. These findings further demonstrate that the mechanism of pneumococcal pathogenesis is highly complex and multifactorial but ascribes a role for each of these virulence proteins, alone or in combination, in the process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17261599      PMCID: PMC1865719          DOI: 10.1128/IAI.01384-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  66 in total

1.  The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin.

Authors:  P Balachandran; S K Hollingshead; J C Paton; D E Briles
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

Review 2.  Current trends in capsular polysaccharide biosynthesis of Streptococcus pneumoniae.

Authors:  E García; D Llull; R Muñoz; M Mollerach; R López
Journal:  Res Microbiol       Date:  2000 Jul-Aug       Impact factor: 3.992

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae.

Authors:  S Hammerschmidt; G Bethe; P H Remane; G S Chhatwal
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

5.  Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif.

Authors:  S Hammerschmidt; M P Tillig; S Wolff; J P Vaerman; G S Chhatwal
Journal:  Mol Microbiol       Date:  2000-05       Impact factor: 3.501

6.  Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae.

Authors:  Priya Balachandran; Alexis Brooks-Walter; Anni Virolainen-Julkunen; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

7.  Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae.

Authors:  H Y Wu; M H Nahm; Y Guo; M W Russell; D E Briles
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

8.  Requirement for capsule in colonization by Streptococcus pneumoniae.

Authors:  A D Magee; J Yother
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

9.  Interaction of pneumolysin-sufficient and -deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa.

Authors:  C F Rayner; A D Jackson; A Rutman; A Dewar; T J Mitchell; P W Andrew; P J Cole; R Wilson
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

10.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

Authors:  Richard Malley; Philipp Henneke; Sarah C Morse; Michael J Cieslewicz; Marc Lipsitch; Claudette M Thompson; Evelyn Kurt-Jones; James C Paton; Michael R Wessels; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

View more
  44 in total

1.  Pneumococcal interactions with epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in vivo.

Authors:  Laura R Marks; G Iyer Parameswaran; Anders P Hakansson
Journal:  Infect Immun       Date:  2012-05-29       Impact factor: 3.441

Review 2.  Mechanisms of Bacterial Colonization of the Respiratory Tract.

Authors:  Steven J Siegel; Jeffrey N Weiser
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

3.  Identification of a novel pneumococcal vaccine antigen preferentially expressed during meningitis in mice.

Authors:  Layla K Mahdi; Hui Wang; Mark B Van der Hoek; James C Paton; Abiodun D Ogunniyi
Journal:  J Clin Invest       Date:  2012-05-24       Impact factor: 14.808

4.  Viability and virulence of pneumolysin, pneumococcal surface protein A, and pneumolysin/pneumococcal surface protein A mutants in the ear.

Authors:  Patricia A Schachern; Vladimir Tsuprun; Sarah Goetz; Sebahattin Cureoglu; Steven K Juhn; David E Briles; Michael M Paparella; Patricia Ferrieri
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-09       Impact factor: 6.223

5.  Pneumococcal Adhesins PavB and PspC Are Important for the Interplay with Human Thrombospondin-1.

Authors:  Ulrike Binsker; Thomas P Kohler; Krystin Krauel; Sylvia Kohler; Hansjörg Schwertz; Sven Hammerschmidt
Journal:  J Biol Chem       Date:  2015-04-20       Impact factor: 5.157

6.  Two DHH subfamily 1 proteins contribute to pneumococcal virulence and confer protection against pneumococcal disease.

Authors:  L E Cron; K Stol; P Burghout; S van Selm; E R Simonetti; H J Bootsma; P W M Hermans
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

Review 7.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

8.  Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.

Authors:  Xiaorui Chen; Bo Li; Jinfei Yu; Yue Zhang; Zujian Mo; Tiejun Gu; Wei Kong; Yong Zhang; Yongge Wu
Journal:  Med Microbiol Immunol       Date:  2019-02-01       Impact factor: 3.402

9.  Mutations in the tacF gene of clinical strains and laboratory transformants of Streptococcus pneumoniae: impact on choline auxotrophy and growth rate.

Authors:  Ana González; Daniel Llull; María Morales; Pedro García; Ernesto García
Journal:  J Bacteriol       Date:  2008-04-18       Impact factor: 3.490

Review 10.  Potential role for mucosally active vaccines against pneumococcal pneumonia.

Authors:  Kondwani C Jambo; Enoch Sepako; Robert S Heyderman; Stephen B Gordon
Journal:  Trends Microbiol       Date:  2009-12-22       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.